Size and growth in 33 countries and regions, with clinical trials and research from public sources.
Market size in 2023 · growth a year to 2033
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)| Place | 2023 | 2033 (projected) | CAGR | World share | Active trials | Report |
|---|---|---|---|---|---|---|
| World | $600 Mn | $1.1 Bn | 6.3% | – | 460 | Report on Creatine in Global |
| North America | $300 Mn | $503 Mn | 5.3% | 50% | 145 | Report on Creatine in North America |
| APAC | $126 Mn | $261 Mn | 7.6% | 21% | 92 | Report on Creatine in APAC |
| Europe | $114 Mn | $186 Mn | 5% | 19% | 116 | Report on Creatine in Europe |
| Latin America | $27 Mn | $55 Mn | 7.3% | 4.5% | 26 | Report on Creatine in Latin America |
| Middle East | $24 Mn | $49 Mn | 7.3% | 4% | 1 | Report on Creatine in Middle East |
| Africa | $9 Mn | $19 Mn | 7.8% | 1.5% | 4 | Report on Creatine in Africa |
| $252 Mn | $384 Mn | 4.3% | 42% | 129 | Report on Creatine in US | |
| $48 Mn | $102 Mn | 7.8% | 8% | 65 | Report on Creatine in China | |
| $48 Mn | $88 Mn | 6.3% | 8% | 30 | Report on Creatine in Canada | |
| $37 Mn | $72 Mn | 6.8% | 6.2% | 12 | Report on Creatine in Japan | |
| $22 Mn | $34 Mn | 4.5% | 3.7% | 35 | Report on Creatine in Germany | |
| $17 Mn | $28 Mn | 5.3% | 2.8% | 42 | Report on Creatine in France | |
| $16 Mn | $24 Mn | 4.3% | 2.6% | 36 | Report on Creatine in UK | |
| $15 Mn | $30 Mn | 7.3% | 2.5% | 22 | Report on Creatine in Brazil | |
| $14 Mn | $25 Mn | 5.8% | 2.4% | 40 | Report on Creatine in Italy | |
| $12 Mn | $23 Mn | 6.9% | 2% | 0 | Report on Creatine in Ecuador | |
| $12 Mn | $19 Mn | 5.3% | 1.9% | 43 | Report on Creatine in Spain | |
| $11 Mn | $27 Mn | 9.3% | 1.8% | 4 | Report on Creatine in India | |
| $10 Mn | $22 Mn | 7.8% | 1.7% | 0 | Report on Creatine in Saudi Arabia | |
| $9 Mn | $17 Mn | 6.6% | 1.5% | 9 | Report on Creatine in Mexico | |
| $7 Mn | $15 Mn | 7.8% | 1.2% | 19 | Report on Creatine in Australia | |
| $4 Mn | $8 Mn | 7.5% | 0.7% | 0 | Report on Creatine in South Africa | |
| $3 Mn | $6 Mn | 7.3% | 0.5% | 1 | Report on Creatine in UAE | |
| $2 Mn | $4 Mn | 7.8% | 0.3% | 4 | Report on Creatine in Egypt | |
| $1 Mn | $3 Mn | 6.8% | 0.2% | 0 | Report on Creatine in Philippines | |
| $1 Mn | $2 Mn | 7.3% | 0.2% | 2 | Report on Creatine in Hong Kong | |
| $1 Mn | $2 Mn | 6.5% | 0.2% | 1 | Report on Creatine in Malaysia | |
| $1 Mn | $1 Mn | 6.9% | 0.1% | 3 | Report on Creatine in Singapore | |
| $1 Mn | $1 Mn | 6.6% | 0.1% | 1 | Report on Creatine in Thailand | |
| $0 Mn | $1 Mn | 7.4% | 0.1% | 0 | Report on Creatine in Kenya | |
| – | – | – | – | 6 | Report on Creatine in New Zealand | |
| – | – | – | – | 6 | Report on Creatine in Russia |
"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Ajinomoto
AlzChem Group
BM PHARM
BSN
Cymbiotika
Glanbia PLC
GNC Holdings Inc
Gulang Xinmiao
Optimum Nutrition
Tiancheng International
Tradichem S.L
Weider Global Nutrition
The world Creatine market was worth about $600 Mn in 2023 and is projected to reach $1.1 Bn by 2033, growing 6.3% a year (CAGR).
The US is the largest of the 24 countries we cover, at $252 Mn in 2023. India grows fastest, at 9.3% a year.
ClinicalTrials.gov lists 460 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
PubMed lists about 493 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.